medline.ch Onkologie

	Decision regret following rapid genetic testing at the time of breast cancer diagnosis. Cancer Hsu LF, Eisen A, Poll A, Lim DW, Wright FC, Hanrahan R, Hosein A, Pal T, Narod S, Metcalfe K. PMID: 42967224 [PubMed - indexed for MEDLINE]
	Liposomal irinotecan and capecitabine plus bevacizumab as second-line therapy in metastatic colorectal cancer: A multicenter, single-arm study. Cancer Su D, Li C, Zheng T, Tang J, Wang G, Xu H, Wang X, Cai Z, Liu C, Zhang Y. PMID: 42967221 [PubMed - indexed for MEDLINE]
	Integrating Systemic Inflammation, Nutrition and Skeletal Muscle into a Composite Score (the HALP-Sarcopenia Combined Index) for Preoperative Risk Stratification of Lymph-Node Metastasis and Recurrence in Endometrial Carcinoma: A Single-Centre Retrospective Study. Int J Womens Health Zhang Q, Guo D, Li D. PMID: 42967187 [PubMed]
	Conversion Surgery After HAIC-Based Combination Therapy with Targeted Therapy and Immune Checkpoint Inhibitors for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study. J Hepatocell Carcinoma Zhang X, Hu J, Lan H, Shen X, Zhou M, Tian Y. PMID: 42967182 [PubMed]
	Early Assessment of Circulating Tumor Cells and Their PD-L1 Expression as Predictive Biomarkers in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: An Exploratory Study. Immunotargets Ther Grolleau E, Barthelemy D, Millet A, Calattini S, Lescuyer G, Komaroff A, Benzerdjeb N, Lebert D, Philouze P, Piecyk M, Guitton J, Couraud S, Payen L. PMID: 42967173 [PubMed]
	Unraveling the EMT Spectrum in Aggressive Breast Cancer: Bridging Molecular Hybrid States with Functional Assay Interpretation. Onco Targets Ther Utami N, Alhaq KF, Oktavia N, Bashari MH, Usman HA, Khairani AF. PMID: 42967165 [PubMed]
	Biomaterial-Enabled Delivery Strategies to Overcome Treatment Resistance in Medulloblastoma. Int J Nanomedicine Sheng Z, Dong Y, Wei J, Li J, Min L, Chen Y, Wang B, Wen Y, Song YX, Wang J, Gao J, Wang X. PMID: 42967130 [PubMed - indexed for MEDLINE]
	Local Recurrence and Oncological Outcomes After Transanal Total Mesorectal Excision With Intersphincteric Resection for Lower Rectal Cancer: A Nationwide Multicenter Cohort Study (Ta-Ta-Mi Study). Ann Gastroenterol Surg Tanabe K, Mori S, Baba K, Matsuda T, Takemasa I, Okabayashi K, Tani C, Manabe T, Kakeji Y, Ohtsuka T, Yamamoto S, Naitoh T, Ta. PMID: 42967081 [PubMed - as supplied by publisher]
	Reconciling Extent of Resection and Residual Tumor Volume in Glioblastoma: Sources of Discordance and a Proposed Reporting Framework. Cureus Okong'o P, Saro-Naenwi N, Johnson J, Jamaria S, Salem A, Yannakula VK, Rai M. PMID: 42967078 [PubMed]
	Protein Lactylation in Cancer: From Mechanisms to Therapy. MedComm (2020) Huang W, Hu P, Wang S, Zhang X, Ye Z, Chen S, Gao F, Chen Y, Yang Y. PMID: 42967077 [PubMed]
	Association between antibiotic exposure and survival outcomes in hepatocellular carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. PeerJ Chen S, Chen S, Li Y, Su J, Yu C, Xu C, Li Q, Wu Q, Sun C. PMID: 42967034 [PubMed - indexed for MEDLINE]
	Enhanced Efficacy of Thalidomide-Based Cocktail With Transarterial Chemoembolization in the Management of Unresectable Hepatocellular Carcinoma: A Multi-Center Cohort Study. MedComm (2020) Xu J, Song L, Kong Y, Li J, Zhang J, Ye T, Liu Y, Yin X, Yang B, Zhao Z, Huang P, Chen Y, Jiang M, Ge N, Wali F, Hu W, Zhu G, Xia J. PMID: 42967027 [PubMed]
	Multilevel Determinants of Liver Cancer Screening Uptake in Community-Based High-Risk Populations in Chongqing, China: A Prospective Cohort Study. J Hepatocell Carcinoma Li B, Yu Z, Zhang Y, Li Q, Liu X, Guo Q, Zhou H, Du J, He M. PMID: 42966914 [PubMed]
	Interplays Between Therapeutic Radiopharmaceuticals and Tumor Microenvironment. Adv Healthc Mater Zhang Y, Zhang Y, Zhao Y, Ma J, Xie X, Qi Z, Li Y, Fei G, Liu Z, Ni Y. PMID: 42966907 [PubMed - as supplied by publisher]
	Non-Invasive Assessment of Perineural Invasion Density: A Novel Marker for Prognosis and Treatment Stratification in Prostate Cancer. Adv Sci (Weinh) Liu B, Zhang L, Zhu W, Yang M, Liu X, Li X, Qin P, Lin Z, Cai Q, Zheng J, Zhao X, Zou C, Wen X, Xu L, Wu D, Zhang L, Zhang C, Li K, Wang C, Zhong W, Luo Y. PMID: 42966879 [PubMed - as supplied by publisher]
	PD-(L)1Ã—VEGF bispecific antibodies in solid tumors: clinical trial updates from ASCO 2026. J Hematol Oncol Wang Z, Guo C, Yuan X, Guo Q, Zhang R, Chen Z. PMID: 42966842 [PubMed - indexed for MEDLINE]
	Survival Outcomes of Segmental Resection Versus Local Tumor Excision in Upper Tract Urothelial Carcinoma: A Population-Based Study. Ann Surg Oncol Liu X, Wang S, Xu Z, Zhang Z, Zhang C. PMID: 42966839 [PubMed - as supplied by publisher]
	Racial Perceptions of Communication in Breast Cancer Diagnosis. J Racial Ethn Health Disparities Hora JA, Almeida MA, Souza ES, Vale DB. PMID: 42966829 [PubMed - as supplied by publisher]
	Lymph node ratio as an independent prognostic factor in non-tongue oral cavity cancer: a retrospective cohort study. Eur Arch Otorhinolaryngol Migliorelli A, Szewczyk M. PMID: 42966791 [PubMed - as supplied by publisher]
	Bone fractures and prior abiraterone use in men treated with radium-223 plus enzalutamide for castration-resistant prostate cancer with bone metastases: a real-world study. Prostate Cancer Prostatic Dis McKay RR, Lunacsek O, Korn MJ, Raval AD. PMID: 42966775 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 1986108

Seite 1 von 99306

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung